32264585|t|Enantiomers of cysteine-modified SeNPs (d/lSeNPs) as inhibitors of metal-induced Abeta aggregation in Alzheimer's disease.
32264585|a|Chiral molecules, which selectively target and inhibit amyloid beta-peptide (Abeta) aggregation, have potential use as therapeutic agents for the treatment of Alzheimer's disease (AD). Here we use cysteine enantiomer-modified SeNPs (abbreviated as d/lSeNPs) to demonstrate that surface chirality strongly influences the formation of Abeta aggregates in the presence of metal ions, such as Zn2+ or Cu2+. The two chiral molecule modified nanoparticles could inhibit the formation of Abeta fibrils by binding Abeta, thus blocking the formation of Abeta fibrils and blocking the metal binding sites. Of the two enantiomers, d/SeNPs appear to more effectively inhibit Abeta fibril formation due to a greater affinity for Abeta than that of l/SeNPs. Additionally, d/lSeNPs appeared to reduce Abeta and metal ion-induced neurotoxicity. Treatment with d/lSeNPs can also decrease the levels of intracellular reactive oxygen species, and stabilize the mitochondrial membrane potential. Of the two enantiomers, d/SeNPs were more effective in protecting the cells than l/SeNPs, and this could be due to d/SeNPs being selectively absorbed by PC12 cells, maintaining cellular redox potentials, and protecting cells against oxidative stress to a greater extent than l/SeNPs. From these results, it appears that chiral molecules can bring novel insight into better drug treatment designs for Alzheimer's disease.
32264585	15	23	cysteine	Chemical	MESH:D003545
32264585	33	38	SeNPs	Chemical	MESH:C059702
32264585	40	48	d/lSeNPs	Chemical	-
32264585	67	72	metal	Chemical	MESH:D008670
32264585	81	86	Abeta	Gene	54226
32264585	102	121	Alzheimer's disease	Disease	MESH:D000544
32264585	200	205	Abeta	Gene	54226
32264585	282	301	Alzheimer's disease	Disease	MESH:D000544
32264585	303	305	AD	Disease	MESH:D000544
32264585	320	328	cysteine	Chemical	MESH:D003545
32264585	349	354	SeNPs	Chemical	MESH:C059702
32264585	371	379	d/lSeNPs	Chemical	-
32264585	456	461	Abeta	Gene	54226
32264585	492	497	metal	Chemical	MESH:D008670
32264585	512	516	Zn2+	Chemical	-
32264585	520	524	Cu2+	Chemical	-
32264585	604	609	Abeta	Gene	54226
32264585	629	634	Abeta	Gene	54226
32264585	667	672	Abeta	Gene	54226
32264585	698	703	metal	Chemical	MESH:D008670
32264585	743	745	d/	Chemical	MESH:D003903
32264585	745	750	SeNPs	Chemical	MESH:C059702
32264585	786	791	Abeta	Gene	54226
32264585	839	844	Abeta	Gene	54226
32264585	858	860	l/	Chemical	MESH:D007930
32264585	860	865	SeNPs	Chemical	MESH:C059702
32264585	881	889	d/lSeNPs	Chemical	-
32264585	909	914	Abeta	Gene	54226
32264585	919	924	metal	Chemical	MESH:D008670
32264585	937	950	neurotoxicity	Disease	MESH:D020258
32264585	967	975	d/lSeNPs	Chemical	-
32264585	1022	1045	reactive oxygen species	Chemical	MESH:D017382
32264585	1125	1130	SeNPs	Chemical	MESH:C059702
32264585	1182	1187	SeNPs	Chemical	MESH:C059702
32264585	1214	1215	d	Chemical	MESH:D003903
32264585	1216	1221	SeNPs	Chemical	MESH:C059702
32264585	1252	1256	PC12	CellLine	CVCL:0481
32264585	1376	1381	SeNPs	Chemical	MESH:C059702
32264585	1499	1518	Alzheimer's disease	Disease	MESH:D000544
32264585	Negative_Correlation	MESH:D003545	MESH:D000544
32264585	Negative_Correlation	MESH:D003545	54226
32264585	Negative_Correlation	MESH:C059702	MESH:D000544
32264585	Positive_Correlation	MESH:D008670	MESH:D020258
32264585	Negative_Correlation	MESH:C059702	54226
32264585	Association	MESH:C059702	MESH:D003545
32264585	Positive_Correlation	MESH:D008670	54226
32264585	Association	MESH:D000544	54226
32264585	Negative_Correlation	MESH:D003903	54226

